AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aylward, B.
Right arrow Articles by Cochi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aylward, B.
Right arrow Articles by Cochi, S.
Related Collections
Right arrow Global Health
Right arrow Immunization/Vaccines
Right arrow Other Infections

American Journal of Public Health, Vol 90, Issue 10 1515-1520, Copyright © 2000 by American Public Health Association

JOURNAL ARTICLE

When is a disease eradicable? 100 years of lessons learned

B Aylward, KA Hennessey, N Zagaria, JM Olive and S Cochi
Expanded Programme on Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland. aylwardb@who.ch

Since the 1915 launch of the first international eradication initiative targeting a human pathogen, much has been learned about the determinants of eradicability of an organism. The authors outline the first 4 eradication efforts, summarizing the lessons learned in terms of the 3 types of criteria for disease eradication programs: (1) biological and technical feasibility, (2) costs and benefits, and (3) societal and political considerations.


This article has been cited by other articles:


Home page
 BMJHome page
R B. Aylward and M. Birmingham
The human story
BMJ, November 26, 2005; 331(7527): 1261 - 1262.
[Full Text] [PDF]

Home page
 Am. J. Public HealthHome page
R. B. Aylward and D. L. Heymann
Can We Capitalize on the Virtues of Vaccines? Insights from the Polio Eradication Initiative
Am J Public Health, May 1, 2005; 95(5): 773 - 777.
[Abstract] [Full Text] [PDF]

Home page
 Nurs EthicsHome page
J. Wood-Harper
Informing Education Policy on MMR: balancing individual freedoms and collective responsibilities for the promotion of public health
Nursing Ethics, January 1, 2005; 12(1): 43 - 58.
[Abstract] [PDF]

Home page
 CMAJHome page
C. Greenaway
Dracunculiasis (guinea worm disease)
Can. Med. Assoc. J., February 17, 2004; 170(4): 495 - 500.
[Abstract] [Full Text] [PDF]

Home page
 Integr. Comp. Biol.Home page
A. G. Evans and T. E. Wellems
Coevolutionary Genetics of Plasmodium Malaria Parasites and Their Human Hosts
Integr. Comp. Biol., April 1, 2002; 42(2): 401 - 407.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Public Health Association